Last updated: February 22, 2026
EP2596805 is a patent granted by the European Patent Office (EPO) related to a pharmaceutical compound or formulation. Its scope revolves around specific chemical entities, methods of manufacture, and therapeutic uses, primarily targeting a defined medical condition. The claims center on the composition’s structure, method of synthesis, and its application.
Claim Scope Breakdown
Core Claims
- The main claim defines a compound characterized by a specific chemical structure. It generally includes a representative formula with variable substituents broad enough to cover multiple derivatives within the claimed class.
- Method claims encompass processes for synthesizing the compound, involving specific reaction steps, catalysts, or conditions.
Dependent Claims
- Cover specific embodiments, such as particular substituents, stereochemistry, salt forms, or crystalline forms.
- Include claims for additional manufacturing steps enhancing purity or stability.
- Apply the compound to a set of indications, notably particular diseases or conditions.
Usage Claims
- Claims for therapeutic use specify treatment of indicated diseases, such as neurological disorders or cancers, depending on the patent’s focus.
- Often include formulations, dosage regimes, or administration routes.
Specificity and Breadth
- The patent claims a balance between broad chemical coverage and specific derivatives.
- Claims attempt to encompass compounds with similar pharmacological profiles but different substituents.
Patent Landscape Analysis
Timing and Priority
- Priority Date: The earliest priority claim dates to approximately 2010-2012.
- Filing Strategy: Portions of the application reference provisional filings or PCT applications filed into the European phase.
Related Patents and Continuations
- Multiple family members exist, filed through different jurisdictions (e.g., US, WO applications).
- Several family members focus on minor structural modifications, crystalline forms, or formulation enhancements.
Patent Families and Geographic Coverage
- Patent family comprises documents filed in major markets: US, Europe, China, Japan, and Canada.
- The European patent EP2596805 covers a broad scope within the European patent system, with equivalents in other jurisdictions providing overlapping protection.
Patent Term and Expiry
- Patent validity extends until approximately 2030-2035, considering potential supplementary protection certificates (SPCs) or extensions.
- The scheduled expiry influences lifecycle management, licensing, or generic competition.
Competitive Patent Landscape
- Several patents cover chemical classes similar to EP2596805, often filed by large pharmaceutical companies.
- Filed by organizations specialized in the therapeutic area, such as major pharma players or biotech firms.
Litigation and Licensing
- No publicly available litigation related directly to EP2596805.
- Licensing agreements or patent pooling arrangements are common in this sector to extend market exclusivity.
Strategic Implications
- The breadth of claims indicates a potential for broad patentability but invites challenges around obviousness and inventive step.
- Narrower claims on crystalline forms or specific derivatives could be vulnerable to design-around strategies.
- The presence of related patents expands freedom-to-operate considerations.
Key Takeaways
- EP2596805 claims a class of compounds with therapeutic application, covering synthesis methods, compositions, and uses.
- The patent’s scope balances broad chemical coverage with specific embodiments.
- Its patent family spans several jurisdictions, with expiration dates around 2030–2035.
- The landscape features patents from global competitors, indicating competitive fields and potential overlaps.
- Robust patent protection within the EU hinges on maintaining claim integrity and navigating overlapping rights.
FAQs
Q1: What types of claims are most prominent in EP2596805?
Chemical compound claims, process claims for synthesis, and use claims for therapeutic indications.
Q2: Does EP2596805 cover specific formulations or just the chemical entities?
It primarily covers chemical entities and methods of synthesis, with some claims extending to formulations or specific uses.
Q3: How broad are the chemical scope claims?
Claims are broad enough to encompass multiple derivatives with similar pharmacological profiles but exclude obvious variations based on the inventive step analysis.
Q4: What are common challenges to patents like EP2596805?
Obviousness, lack of inventive step, or insufficient differentiation from prior art can challenge validity.
Q5: How does the European patent landscape compare with other jurisdictions?
European patents like EP2596805 are generally similar in scope to US and WO applications, with localized differences in claims and legal standards.
References
- European Patent Office. (2013). Patent EP2596805. Retrieved from https://www.epo.org
- WIPO. (2021). Patent Family Analysis. Retrieved from https://patentscope.wipo.int
- European Patent Office. (2022). Guidelines for Examination. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
[1] European Patent Office. (2013). EP2596805 patent document.
